Kathy Castor (D-FL)

Advancing Safe Medications for Moms and Babies Act of 2026

H.R. 8651 · House bill Health

A Democratic bill with 1 Republican cosponsor · See all 2 cosponsors

Last activity — Referred to the House Committee on Energy and Commerce.

In committee

Introduced and handed to a committee in the chamber it started in.

The committee holds it, and most bills are never heard from again. A hearing or a committee vote would be news; silence is the usual outcome, and it kills the bill without anyone voting against it.

Its path through Congress

  1. Introduced
  2. In Committee

What this bill would do

The Advancing Safe Medications for Moms and Babies Act of 2026 aims to increase the inclusion of pregnant and lactating women in clinical research. It directs the FDA to harmonize regulations to better protect and include these women in research studies. The bill also requires an education campaign to inform patients and providers about the benefits of research and how to find clinical trials. Additionally, the NIH is tasked with prioritizing research projects specifically concerning drugs used by pregnant and lactating women. This includes establishing a process to fund research based on medical needs and disease severity.

Yes· 3 of 7

  • Scored +6

    Would women be better off under this?

    The bill directly benefits women by promoting their inclusion in clinical research and addressing their specific medical needs.

  • Scored +6

    Does this put more money into medical research?

    The bill authorizes specific funding for the NICHD to carry out priority research projects concerning drugs used by pregnant and lactating women.

  • Scored +6

    Does this put more money into scientific research?

    The bill mandates priority research projects through the NICHD to address unmet medical needs in pregnant and lactating populations.

The opposite

No question was scored the opposite.